Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease

被引:30
|
作者
Silvestrini, Mauro [1 ]
Viticchi, Giovanna [1 ]
Altamura, Claudia [2 ]
Luzzi, Simona [1 ]
Balucani, Clotilde [3 ]
Vernieri, Fabrizio [2 ]
机构
[1] Univ Politecn Marche, Neurol Clin, I-60020 Ancona, Italy
[2] Campus Biomed Univ, Neurol Clin, Rome, Italy
[3] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA
关键词
Alzheimer's disease; vascular markers; vascular risk factors; WHITE-MATTER LESIONS; MILD COGNITIVE IMPAIRMENT; INTIMA-MEDIA THICKNESS; CEREBRAL VASOMOTOR REACTIVITY; GLYCATION END-PRODUCTS; MIDLIFE BLOOD-PRESSURE; APOLIPOPROTEIN-E; CAROTID ATHEROSCLEROSIS; AMYLOID-BETA; ATRIAL-FIBRILLATION;
D O I
10.3233/JAD-2012-121240
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence is emerging that vascular disease and its risk factors play a role in the development of Alzheimer's disease (AD) and affect the probability of an adverse outcome. The aims of this review are to explore the relationship between vascular risk factors and AD and to discuss the potential use of vascular markers in the clinical approach to cognitive impairment. Moreover, we present evidence about the potential use of ultrasonographic and neuroradiologic markers of cognitive impairment in order to establish possible treatment strategies in subjects with a clinical profile at risk of developing AD.
引用
收藏
页码:689 / 698
页数:10
相关论文
共 50 条
  • [21] Cerebrovascular disease in ageing and Alzheimer’s disease
    Seth Love
    J. Scott Miners
    Acta Neuropathologica, 2016, 131 : 645 - 658
  • [22] Cerebrovascular Reactivity to Carbon Dioxide in Alzheimer's Disease
    Glodzik, Lidia
    Randall, Catherine
    Rusinek, Henry
    de Leon, Mony J.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (03) : 427 - 440
  • [23] Testosterone and Alzheimer's disease: a risk assessment
    Kawada, Tomoyuki
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2024, 39 (08) : 955 - 956
  • [24] Genetic risk assessment for adult children of people with Alzheimer's disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study
    Roberts, JS
    Cupples, LA
    Relkin, NR
    Whitehouse, PJ
    Green, RC
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2005, 18 (04) : 250 - 255
  • [25] Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?
    Hadjihambi, Anna
    ANALYTICAL BIOCHEMISTRY, 2022, 636
  • [26] Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements
    Ding, Huitong
    Ye, Zehao
    Paschalidis, Aris
    Bennett, David A.
    Au, Rhoda
    Lin, Honghuang
    ALZHEIMERS & DEMENTIA, 2025, 21 (03)
  • [27] Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease
    Chen, J. J.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [28] Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease
    Lee, Heeyoung
    Kim, EunYoung
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (09) : 932 - 960
  • [29] Untangling Genetic Risk for Alzheimer's Disease
    Pimenova, Anna A.
    Raj, Towfique
    Goate, Alison M.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (04) : 300 - 310
  • [30] Vascular risk factors for Alzheimer's disease
    Levin, O. S.
    Trusova, N. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (07) : 3 - 12